Heather I. Cook

Exeter, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Needle aspiration versus intercostal chest drain for secondary spontaneous pneumothorax (the PRINCE-SSP trial): a pragmatic, open-label, multi-centre, non-inferiority, randomised controlled trial.

Needle aspiration versus intercostal chest drain for secondary spontaneous pneumothorax (the PRINCE-SSP trial): a pragmatic, open-label, multi-centre, non-inferiority, randomised controlled trial.

Journal: The European respiratory journal

Published: February 19, 2026

HIP Surgical Techniques to Enhance Rehabilitation (HIPSTER) : a single-centre, double-blind, parallel three-arm, randomized-controlled, superiority trial.

HIP Surgical Techniques to Enhance Rehabilitation (HIPSTER) : a single-centre, double-blind, parallel three-arm, randomized-controlled, superiority trial.

Journal: Bone & joint open

Published: August 27, 2025

Evaluation of Out-of-Hospital Use of a Valsalva Assist Device in the Emergency Treatment of Supraventricular Tachycardia.

Evaluation of Out-of-Hospital Use of a Valsalva Assist Device in the Emergency Treatment of Supraventricular Tachycardia.

Journal: Annals of emergency medicine

Published: May 08, 2025

Pragmatic non-inferiority Randomised trial Investigating Needle aspiration versus ChEst drain for Secondary Spontaneous Pneumothorax (the PRINCE-SSP study): study protocol for a randomised non-inferiority trial.

Pragmatic non-inferiority Randomised trial Investigating Needle aspiration versus ChEst drain for Secondary Spontaneous Pneumothorax (the PRINCE-SSP study): study protocol for a randomised non-inferiority trial.

Journal: BMJ open

Published: December 26, 2024

Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.

Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.

Journal: Health technology assessment (Winchester, England)

Published: October 14, 2024

Epigenetic deprogramming by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers.

Epigenetic deprogramming by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers.

Journal: The Journal of cell biology

Published: September 25, 2024

Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiences.

Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiences.

Journal: The British journal of general practice : the journal of the Royal College of General Practitioners

Published: May 22, 2024

Protocol for a feasibility randomised controlled trial of the 'Outdoor' mobility intervention for older adults after hip fracture.

Protocol for a feasibility randomised controlled trial of the 'Outdoor' mobility intervention for older adults after hip fracture.

Journal: PloS one

Published: February 20, 2024

The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience.

The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience.

Journal: Trials

Published: November 20, 2023

Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trial.

Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trial.

Journal: Journal of advanced nursing

Published: June 14, 2023

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: June 03, 2023

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.

Journal: Trials

Published: December 28, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026